Signup to receive the UMDF newsletter in your email monthly at umdf.org/newsletter-signup. UMDF Preps for Mitochondrial Disease Awareness Week...
Read moreSept. 4, 2025 — Earlier today, Saol Therapeutics shared the U.S. Food and Drug Administration (FDA) has issued a Complete Response...
Read moreSignup to receive the UMDF newsletter in your email monthly at umdf.org/newsletter-signup. ...
Read moreWe’re excited to unite with other mitochondrial disease-focused patient advocacy groups across the globe to spread awareness on World...
Read moreBarth Syndrome Foundation, UMDF, and MitoAction leadership were recently notified by Stealth BioTherapeutics that FDA has refused their request...
Read moreSignup to receive the UMDF newsletter in your email monthly at umdf.org/newsletter-signup. The Mito Fund Announces Investment in Pretzel...
Read moreSignup to receive the UMDF newsletter in your email monthly at umdf.org/newsletter-signup. UMDF Launches New Mito Biorepository with...
Read moreUMDF has partnered with the nonprofit COMBINEDBrain to develop a mitochondrial disease biorepository hosted on mitoSHARE, UMDF’s patient...
Read more